Form4insider filings, from the source

SEC Form 4 · accession 0001179110-16-020574

AMAG PHARMACEUTICALS INC. · AMAG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
William K Heiden
Officer — CEO · Director
Period of report
Feb 26, 2016
Accepted (ET)
Mar 1, 2016 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 26, 2016F10,649$27.01D190,072D
Common StockF2Feb 26, 2016F4,070$27.01D186,002D
Common StockF3Feb 27, 2016F1,843$27.01D184,159D
Common StockF4Feb 29, 2016F1,701$26.28D182,458D
Common StockF5,F6,F8Mar 1, 2016A36,000—A218,458D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F8,F7$25.18Mar 1, 2016A85,000A—Mar 1, 2026Common Stock85,00085,000D

Explanation of responses